The trial will focus on evaluating the Kiva System against Medtronic’s Kyphon Balloon Kyphoplasty. The trial enrolled 300 patients and is being conducted to support a subsequent 510(k) filing for market clearance from the U.S. Food and Drug Administration.
More Articles on Orthopedic Devices:
Medtronic Receives 510(k) Approval for Orthopedic Sealer
